Product Information
TELMISARTAN 40 MG TABLET is a generic product labeled by Ascend Laboratories, LLC, priced at $0.1600 per EA under NDC 67877048330. Its NADAC has been published 343 times since Dec 4, 2019.
Strength
40 mg/1
Manufacturer
Ascend Laboratories, LLCNDC
67877048330
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
TELMISARTANApproval Type
Generic (ANDA)
FDA Application
ANDA205150On Market Since
6/12/2016
Pharmacological Classes
Price Statistics
The NADAC for TELMISARTAN 40 MG TABLET has been published 343 times since Dec 4, 2019, and over the history we have for it it has declined 70.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1600 per EA |
|---|---|
| All-time high | $0.6457 (Jan 15, 2020) |
| All-time low | $0.1274 (Nov 20, 2024) |
| 52-week high | $0.1881 |
| 52-week low | $0.1600 |
| Median price | $0.2649 |
| Average price | $0.2986 |
| Largest weekly change | -33.0% (Nov 20, 2024) |
| Weeks tracked | 343 |
| Tracking since | Dec 4, 2019 |
Generic Alternatives
The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of TELMISARTAN 40 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for TELMISARTAN 40 MG TABLET, manufactured by Ascend Laboratories, LLC, is $0.1600 per EA (NDC 67877048330), effective Jun 24, 2026.
How has the price of TELMISARTAN 40 MG TABLET changed over time?
Over the history we have for it, the NADAC for TELMISARTAN 40 MG TABLET has declined 70.9%. It has been tracked across 343 weekly CMS publications since Dec 4, 2019.
What are the highest and lowest recorded NADAC prices for TELMISARTAN 40 MG TABLET?
Since Dec 4, 2019, the NADAC for TELMISARTAN 40 MG TABLET has ranged from a low of $0.1274 (Nov 20, 2024) to a high of $0.6457 (Jan 15, 2020), with a median of $0.2649 per EA.
Are there cheaper alternatives to TELMISARTAN 40 MG TABLET?
3 NADAC-published products share the same active ingredient, strength, and dosage form as TELMISARTAN 40 MG TABLET, but none are currently priced below it.
Who manufactures TELMISARTAN 40 MG TABLET?
TELMISARTAN 40 MG TABLET (NDC 67877048330) is labeled by Ascend Laboratories, LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification